GlassScriptPhysician profile
Jennifer Len Yeh
NPI 1346415353
$7,891.15
in general payments reported to CMS, 2019-2025
35 companies · $1,354 in 2025
The $1,354 reported for 2025 was more than what 77% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $999 · 2020: $597 · 2021: $804 · 2022: $1,181 · 2023: $1,341 · 2024: $1,614 · 2025: $1,354.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,309.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,309.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $1,583.17 | 2019-2025 | Repatha, Repatha |
| E.R. Squibb & Sons, L.L.C. | $824.36 | 2019-2025 | Camzyos, Eliquis |
| Astrazeneca Pharmaceuticals LP | $755.06 | 2019-2025 | Farxiga |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $688.73 | 2019-2025 | Lifevest |
| Novartis Pharmaceuticals Corporation | $584.61 | 2019-2025 | |
| Janssen Pharmaceuticals, INC | $486.56 | 2019-2024 | Xarelto |
| Boehringer Ingelheim Pharmaceuticals, INC. | $441.72 | 2019-2025 | Jardiance |
| Medtronic, INC. | $418.71 | 2021-2025 | Micra, Aurora Ev-Icd Mri Surescan, Linq II |
| Cvrx, INC. | $368.46 | 2023-2025 | Barostim Neo System |
| Pfizer INC. | $265.12 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $240.56 | 2022-2025 | Verquvo, Capvaxive |
| Atricure, INC. | $165.81 | 2024 | |
| Philips North America LLC | $128.05 | 2020-2023 | |
| Alnylam Pharmaceuticals INC. | $105.17 | 2019-2025 | Onpattro |
| Abiomed | $92.93 | 2019-2021 |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lexicon Pharmaceuticals, INC. | $92.43 | 2023-2024 | Inpefa |
| Boston Scientific Corporation | $64.76 | 2022-2025 | Watchman Flx |
| Sanofi-Aventis U.S. LLC | $58.95 | 2019-2024 | |
| Esperion Therapeutics, INC. | $58.66 | 2021-2025 | Nexletol |
| Vital Connect, INC | $57.53 | 2024 | Vitalpatch Rtm |
| Bayer Healthcare Pharmaceuticals INC. | $51.70 | 2021-2025 | |
| Cardiva Medical, INC. | $49.19 | 2024-2025 | Optowire |
| Astellas Pharma US INC | $42.92 | 2019-2020 | |
| Medtronic Vascular, INC. | $42.73 | 2019-2020 | |
| Baxter Healthcare | $33.94 | 2023-2024 | Hillrom - Carnation Ambulatory Monitor |
| Regeneron Healthcare Solutions, INC. | $30.16 | 2019 | |
| Teleflex LLC | $27.79 | 2023 | Turnpike |
| Medicomp INC | $26.04 | 2022 | |
| Lemaitre Vascular, INC. | $17.84 | 2023 | Artegraft Vascular Graft |
| Lantheus Medical Imaging, INC. | $15.80 | 2022 | |
| Celonova Biosciences, INC. | $15.47 | 2020 | |
| Kiniksa Pharmaceuticals International, Plc | $15.34 | 2024 | Arcalyst |
| Actelion Pharmaceuticals US, INC. | $14.91 | 2020 | |
| Glaxosmithkline, LLC. | $13.48 | 2019 | |
| Bardy Diagnostics, INC. | $12.49 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jennifer Yeh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.